Table 4 Comparison of survival (OS) in patients with luminal BC and patients with TNBC
Luminal BC | TNBC | |||
|---|---|---|---|---|
Patient groups | No of events/No of patients | No of events/No of patients | Hazard ratio | P Value |
(%) | (%) | (95%CI) | ||
All | 66/496 (13) | 36/137 (26) | 0.45 (0.3-0.68) | < 0.001 |
Age | ||||
< 70 | 41/380 (11) | 22/106 (21) | 0.48 (0.29-0.81) | 0.006 |
> = 70 | 25/116 (22) | 14/31 (45) | 0.34 (0.17-0.65) | 0.001 |
Tumor size (cm) | ||||
< = 2 | 36/346 (10) | 18/84 (21) | 0.44 (0.25-0.78) | 0.005 |
> 2 | 30/146 (21) | 18/50 (36) | 0.49 (0.27-0.87) | 0.016 |
Lymph node involvementa | ||||
Negative | 31/314 (10) | 11/84 (13) | 0.78 (0.39-1.55) | 0.472 |
Positive | 35/176 (20) | 23/45 (51) | 0.3 (0.18-0.5) | < 0.001 |
Stage | ||||
I | 22/257 (9) | 7/61 (11) | 0.78 (0.33-1.82) | 0.563 |
II | 18/161 (11) | 13/43 (30) | 0.32 (0.16-0.65) | 0.002 |
III | 24/66 (36) | 14/23 (61) | 0.43 (0.22-0.83) | 0.012 |
Histologic grade | ||||
I, II | 44/375 (12) | 14/48 (29) | 0.32 (0.18-0.59) | < 0.001 |
III | 22/118 (19) | 22/86 (26) | 0.7 (0.39-1.26) | 0.23 |
Adipose tissue invasionb | ||||
Negative | 4/54 (7) | 3/35 (9) | 0.73 (0.16-3.24) | 0.675 |
Positive | 62/442 (14) | 33/102 (32) | 0.4 (0.26-0.6) | < 0.001 |